Inflammatory markers and coronary heart disease

Area of Science:

• Cardiology
• Inflammation Biology
• Preventive Medicine

Background:

• Coronary heart disease remains a leading cause of death despite lifestyle changes and cholesterol-lowering drugs.
• Current cholesterol screening misses nearly 50% of individuals who will experience acute coronary syndromes.
• Atherosclerosis is increasingly understood as an inflammatory process, not just lipid deposition.

Purpose of the Study:

• To review the clinical utility of inflammatory markers, specifically C-reactive protein, in cardiovascular disease.
• To explore the role of C-reactive protein in risk assessment and guiding therapy for coronary heart disease.

Main Methods:

• Review of laboratory and prospective clinical studies on C-reactive protein and cardiovascular events.
• Analysis of C-reactive protein's stability and availability for automated measurement.
• Examination of C-reactive protein's predictive value in apparently healthy individuals and those with acute coronary syndromes.

Main Results:

• C-reactive protein is a consistent prognostic indicator in acute coronary syndromes.
• C-reactive protein strongly predicts future coronary events in healthy individuals, including those with normal lipid levels.
• C-reactive protein has the potential to guide the use of anti-inflammatory therapies like aspirin and statins for primary prevention.

Conclusions:

• C-reactive protein may enhance global risk assessment for primary cardiovascular prevention.
• C-reactive protein can help identify patients who would benefit from anti-inflammatory treatments.
• C-reactive protein serves as a valuable prognostic marker in patients experiencing acute coronary syndromes.